The serum matrix metalloproteinase-7 level (MMP7) assessment showed a significant correlation with nodal metastases in patients with bladder cancer with sensitivity and specificity of 82% and 71%, respectively, at serum concentrations 7.15 ng/mL [30,31]. This evidence concerns the gene MMP7 and urinary bladder carcinoma.